Italy
Catholic University of Milan - Department of Life Sciences and Public Health
booster dose - Sars-Cov2 vaccine - effectiveness - Omicron VOC Sars-Cov2 vaccine - symptomatic Omicron infection - risk of hospitalization - waning immunity
Genetics, genomics, clinical trials, industry, transparency